Melacine melanoma vaccine: Will begin this year a Phase III trial in 300 patients, comparing the agent given with interferon alfa-2b to interferon alone. End po

Ribi ImmunoChem Research Inc. (RIBI), Hamilton, Mont. Product: Melacine melanoma vaccine, with Detox adjuvant and lysate of human melanoma cells as the antigen Indication: Stage IV, disseminated mela...